Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

MK-677 for Muscle Growth: Dosing, Side Effects, and Compound Comparison

MK-677 25mg daily oral Ghrelin receptor agonist; elevates GH/IGF-1 1.5–3 kg (without training); 2–4 kg (with training) Increased appetite, transient insulin resistance, water retention Best for individuals seeking GH elevation without injections or testosteron

This comparison does not assign a generated winner or score.

  • MK-677
  • 25mg daily oral
  • Ghrelin receptor agonist; elevates GH/IGF-1
  • 1.5–3 kg (without training); 2–4 kg (with training)
  • Increased appetite, transient insulin resistance, water retention
  • Best for individuals seeking GH elevation without injections or testosterone suppression; requires training and protein optimization for meaningful hypertrophy
  • Exogenous GH
  • 2–4 IU daily subcutaneous
  • Direct GH replacement
  • 2–5 kg (with training)
  • Edema, joint pain, carpal tunnel, costly
  • Superior anabolic effect but suppresses natural GH production; significantly more expensive than MK-677
  • Testosterone (250mg/week)
  • 250mg weekly intramuscular
  • Androgen receptor agonist
  • 4–7 kg (with training)
  • Suppression of endogenous testosterone, estrogen conversion, cardiovascular strain
  • Most potent anabolic option; direct muscle protein synthesis; requires post-cycle therapy
  • Ipamorelin
  • 200–300mcg 2–3× daily subcutaneous
  • GHRP; stimulates pulsatile GH release
  • 1–2.5 kg (with training)
  • Minimal; transient cortisol elevation at high doses
  • Pulsatile GH secretagogue; shorter half-life than MK-677; often stacked with CJC-1295
  • The comparison above clarifies where MK-677 for muscle growth fits within the broader landscape of performance-enhancing research compounds. It produces modest but measurable lean mass accrual without androgen receptor activation or endocrine suppression, making it a lower-risk option for individuals exploring growth hormone axis manipulation. The trade-off is slower, smaller gains compared to anabolic androgens—but also faster recovery, no post-cycle therapy requirement, and preserved natural testosterone production.
More references

Related material